two new drugs for overactive bladder

February 2005

You'll see two new drugs for overactive bladder...Vesicare (solifenacin) and Enablex (darifenacin).

They'll compete with other antimuscarinics for overactive bladder...Ditropan, Detrol, Oxytrol, Sanctura.

Vesicare and Enablex are more selective for the M3 muscarinic receptors in the bladder than the other agents.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

what to do about COX-2 inhibitors and other NSAIDs
Asthma updated guidelines for treating asthma during pregnancy
Strattera has a new bolded warning about severe liver injury
Equetro (EE-kwa-tro) for bipolar disorder
Hematology & Oncology Evista (raloxifene) can help prevent breast cancer in postmenopausal women with osteoporosis
Cardiology Patients on amiodarone (Cordarone) will now get a Medication Guide
Cardiology More cardiologists will monitor C-reactive protein (CRP) levels
Diabetes There's now a hemoglobin A1C test for HOME use called ChoiceDM A1c Home Test
Renal & Urology two new drugs for overactive bladder
Campral (acamprosate) is a new option for alcohol dependence
Women's Health oral contraceptives may be less effective in overweight women
Women's Health Clindesse (clin-DESS) is a new option for bacterial vaginosis
Supplements Airborne is flying off the shelves
Men's Health Many men are NOT being screened for osteoporosis
Practice annual chart of new drugs approved by the FDA in 2004